Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
KKR to Sell about $1.6bn worth of its Stake in Kokusai Electric
Private equity firm KKR plans to cut its stake in Kokusai Electric, two people familiar with the matter said, cashing in after a blistering run for shares in the Japanese chip equipment maker. KKR, which holds around 43% of Kokusai's shares, plans to sell about half...
Engie and CDPQ Team Up with €4bn Bid for UK’s Electricity North West Against Iberdrola
European utility Engiehas joined forces with Canada's second-largest pension fund to try to buy British power network Electricity North West (ENWL), according to two sources with knowledge of the matter. The consortium formed by Engie and Caisse de dépôt et placement...
Carlyle to Acquire Baxter’s kidney care unit in a $4bn Valued Deal
Private equity firm Carlyle Group is in exclusive discussions to purchase Baxter International’s kidney care spinoff, Vantive, in a deal valued at around $4bn including debt, according to reports by Reuters and the Wall Street Journal. The report cites an unnamed...